Rafael Fonseca, Md, Discusses Frontline Multiple Myeloma Treatment Patterns

Rafael Fonseca, MD, discusses frontline multiple myeloma treatment patterns

Rafael Fonseca discusses MOA and Its Impact on Myeloma Treatment

Rafael Fonseca, MD, discusses maintenance regimens for multiple myeloma

Is Multiple Myeloma Curable? Rafael Fonseca, M.D., Mayo Clinic

Pathological optimism: seeking a cure for multiple myeloma | Rafael Fonseca, M.D. | Mayo Clinic

What is Multiple Myeloma? | Dr. Rafael Fonseca, M.D. | The Patient Story

The Patient Story

What are the symptoms of multiple myeloma? Rafael Fonseca, M.D., Mayo Clinic

What causes multiple myeloma? Rafael Fonseca, M.D., Mayo Clinic

Multiple Myeloma: Looking Ahead | Dr. Rafael Fonseca (5/5) | The Patient Story

The Patient Story

Final Thoughts on Modern Treatment of Myeloma

Real-world treatment patterns & outcomes among patients with triple-class exposed myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Fonseca on FISH Testing in Patients With Myeloma

How long can I live with multiple myeloma? Rafael Fonseca, M.D., Mayo Clinic

Key Take Aways from IMS 2023 | Rafael Fonseca, MD | IMS 2023

HealthTree Foundation for Multiple Myeloma

Multiple Myeloma: First Line Treatment & Side Effects | Dr. Rafael Fonseca | The Patient Story

The Patient Story

Strategies for Upfront Therapy in Multiple Myeloma

The current frontline treatment strategy in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Seeking specialty care for multiple myeloma Rafael Fonseca, M.D., Mayo Clinic

Rafael Fonseca, MD, On CAR T-cell Therapies in Earlier Myeloma Treatment Lines

Blood Cancers Today

Uses of MRD in patients with multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc